Afatinib dimaleate
| Afatinib dimaleate | |
|---|---|
| Term | Afatinib dimaleate |
| Short definition | Afatinib dimaleate (ay-FA-tih-nib dy-MAY-lee-AYT) drug used to treat certain types of non-small cell lung cancer that have spread to other parts of the body. It is used in patients whose cancer has not yet been treated and who have certain mutations (changes) in the cancerEGFRgene or whose cancer has gotten worse after treatment with platinum chemotherapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Afatinib dimaleate - (pronounced) (ay-FA-tih-nib dy-MAY-lee-AYT) drug used to treat certain types of non-small cell lung cancer that have spread to other parts of the body. It is used in patients whose cancer has not yet been treated and who have certain mutations (changes) in the cancerEGFRgene or whose cancer has gotten worse after treatment with platinum chemotherapy. It is also being studied in the treatment of other types of cancer. Afatinib dimaleate blocks certain proteins made by theEGFRGene that can help stop cancer cells from growing. It can also prevent the growth of new blood vessels that tumors need to grow. Afatinib dimaleate is a type of tyrosine kinase inhibitor and a type of anti-angiogenesis agent. Also called Gilotrif
External links
- Medical encyclopedia article on Afatinib dimaleate
- Wikipedia's article - Afatinib dimaleate
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski